期刊
CELLULAR AND MOLECULAR LIFE SCIENCES
卷 74, 期 5, 页码 837-847出版社
SPRINGER BASEL AG
DOI: 10.1007/s00018-016-2366-z
关键词
Immunology; Antibody; Immunoglobulin; Glycan; Glycobiology; Immunotherapy
资金
- DOC scholarship by the Austrian Academy of Sciences (OAW)
- Swiss National Multiple Sclerosis Society
- Sassella Foundation
- Hartmann Muller Foundation
- Novartis Foundation for medical-biological research
Immunoglobulin gamma (IgG) antibodies are key effector proteins of the immune system. They recognize antigens with high specificity and are indispensable for immunological memory following pathogen exposure or vaccination. The constant, crystallizable fragment (Fc) of IgG molecules mediates antibody effector functions such as complement-dependent cytotoxicity, antibody-mediated cellular cytotoxicity, and antibody-dependent cell-mediated phagocytosis. These functions are regulated by a single N-linked, biantennary glycan of the heavy chain, which resides just below the hinge region, and the presence of specific sugar moieties on the glycan has profound implications on IgG effector functions. Emerging knowledge of how Fc glycans contribute to IgG structure and functions has opened new avenues for the therapeutic exploitation of defined antibody glycoforms in the treatment of cancer and autoimmune diseases. Here, we review recent advances in understanding proinflammatory IgG effector functions and their regulation by Fc glycans.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据